Skip to main content
. 2021 Sep 30;9(3):611–625. doi: 10.9745/GHSP-D-20-00607

TABLE 5.

Screening Rates During and After Enrollment Into the Program Evaluation

PHQ-2 Screening,a % Complete PHQ-9 Screening,b %  
Program enrollment period (Apr. 2017–Nov. 2018) 91.8 90.5
Brief follow-up period (Feb. 2019–May 2019) 25.1 58.8

Abbreviations: PHQ-2, Patient Health Questionnaire-2; PHQ-9, Patient Health Questionnaire-9.

a Among all new antiretroviral therapy initiators.

b Among those who endorse the PHQ-2.